The First Joint Symposium of AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers was held.
31 January - 2 February 2024 | Kyoto International Conference Center
February 2024
The "Japan Initiative for World-leading Vaccine Research and Development Centers " was launched in 2022, and is managed by the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) of the Japan Agency for Medical Research and Development (AMED).
The initiative includes a flagship center and four synergy centers, working collaboratively to drive research and development.
Additionally, six supporting institutions provide support roles for such as experimental animal models and genome analysis.
Our shared vision is to protect people from infectious diseases and pandemics. Researchers from all across Japan are joining forces to address infectious disease prevention and vaccine development.
Flagship Center
Synergy Centers
Support Institutions
Human immunology analyse
Kyoto University
RIKEN
Genome analysis
University of Tokyo
Small experimental animal models
Central Institute for Experimental Medicine and Life Science
Large experimental animal models
National Institutes of Biomedical Innovation, Health and Nutrition
Shiga University of Medical Science
